Core Insights - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report, having recovered millions for shareholders [1] - The firm is investigating several mergers involving different companies, including AlphaTime Acquisition Corp., Cartica Acquisition Corp., Launch One Acquisition Corp., and Aimei Health Technology Co., Ltd. [1][2][3][4] Group 1: Company Investigations - AlphaTime Acquisition Corp. (NASDAQ: ATMCR) is involved in a merger with HCYC Holding Co., where AlphaTime shares will be cancelled in exchange for Class A shares of HCYC [1] - Cartica Acquisition Corp. (OTCMKTS: CRTAF) is merging with Nidar Infrastructure Ltd., with a pre-transaction equity value of approximately $2.75 billion [1] - Launch One Acquisition Corp. (NASDAQ: LPAA) is merging with Minovia Therapeutics Ltd., allowing shareholders a one-to-one exchange of shares in the new entity, Mito US One Ltd. [2] - Aimei Health Technology Co., Ltd (NASDAQ: AFJKU) is merging with United Hydrogen Global, Inc., offering shareholders either a redemption of shares for $10.00 or Class A shares in the combined company with minimal voting influence [3] Group 2: Firm Overview - Monteverde & Associates PC is a national class action securities firm based in the Empire State Building, with a successful track record in trial and appellate courts, including the U.S. Supreme Court [4] - The firm emphasizes that no company, director, or officer is above the law, and encourages shareholders with concerns to reach out for additional information [5]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 10 East 53rd Street, Suite 3001 New York, NY 10022 (Address of pri ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41880 10 East 53rd Street, Suite 3001 New York, NY 10022 (Address of principal executive offices) (Zip Code) Registrant's telephone n ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Title of each Class Trading Symbol(s) Name of each exchange on which registered Ordinary Shares, par value $0.0001 per share AFJK The Nasdaq Stock Market LLC Rights, exchangeable into one-fifth of one Ordinary ShareAFJKR The Nasdaq Stock Market LLC Units, each consisting of one Ordinary Share and one RightAFJKU The Nasdaq Stock Market LLC FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41880 AIMEI HEALTH TECHNOLOGY CO., LTD (Exact name of registrant as specified in its charter) Cayman Islands (State or other jurisdiction o ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Title of each Class Trading Symbol(s) Name of each exchange on which registered Ordinary Shares, par value $0.0001 per share AFJK The Nasdaq Stock Market LLC Rights, exchangeable into one-fifth of one Ordinary ShareAFJKR The Nasdaq Stock Market LLC Units, each consisting of one Ordinary Share and one RightAFJKU The Nasdaq Stock Market LLC FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to ________________ Commission file number: 001-41880 AIMEI HEALTH TECHNOLOGY CO., LTD. (Exact name of registrant as specified in its charter) | --- | --- | |-------- ...